Press releases from collaborating institutions or major pharmaceutical companies

Proactive Vaccinology Yields Nanomedicine Vaccine for All Coronaviruses

May 6, 2024, 03:25 PM

Researchers have developed a new vaccine technology that offers protection against a broad spectrum of coronaviruses, including those not yet identified. This proactive approach in vaccinology involves designing and preparing vaccines in advance of potential pandemics. The technology, which has been tested in mice, is a significant step towards creating a universal vaccine capable of addressing multiple coronavirus strains. Collaborations for this development include institutions like Cambridge University and entities such as NatureNano and HowarthSci, emphasizing its potential in nanomedicine.